ArticleCancer medicine2019

Incidence and outcome of BCR-ABL mutated chronic myeloid leukemia patients who failed to tyrosine kinase inhibitors.

Gabriel Etienne et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.